Patient presents with a history of uterine cancer (endometrial carcinoma), diagnosed on [Date of Diagnosis].  Initial staging was [Stage] based on [Staging System used, e.g., FIGO 2009].  Primary tumor histology was [Histological Type, e.g., endometrioid adenocarcinoma, serous carcinoma] with grade [Grade].  Initial treatment included [Treatment Modalities, e.g., total hysterectomy, bilateral salpingo-oophorectomy, pelvic and para-aortic lymphadenectomy, radiation therapy, chemotherapy] completed on [Date of Treatment Completion].  Patient is currently [Disease Status, e.g., in remission, with persistent disease, with recurrent disease]. Surveillance includes [Surveillance Modalities, e.g., physical examination, CA-125 levels, imaging studies] with frequency of [Frequency of Surveillance].  Current symptoms include [Current Symptoms, e.g., asymptomatic, vaginal bleeding, pelvic pain, abdominal distension] and are attributed to [Attribution of Symptoms, e.g., history of uterine cancer, treatment side effects, unrelated condition].  Physical examination reveals [Relevant Physical Exam Findings].  Plan includes [Plan of Care, e.g., continued surveillance, further investigation of symptoms, referral to oncology, supportive care].  Assessment includes [Assessment, e.g., stable disease, disease progression, treatment response].  ICD-10 code Z85.820 (personal history of malignant neoplasm of uterus) is applicable.  Differential diagnoses considered at initial presentation included [Differential Diagnoses, e.g., endometrial hyperplasia, uterine fibroids, ovarian cancer].  Relevant medical billing codes may include [CPT codes for procedures performed, e.g., specific codes for follow-up visits, imaging studies, laboratory tests].